FNA (Paragon 28) EBIT per Share : $-0.66 (TTM As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Paragon 28 EBIT per Share?

Paragon 28's EBIT per Share for the three months ended in Sep. 2024 was $-0.11. Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 was $-0.66.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Paragon 28's EBIT per Share or its related term are showing as below:

FNA's 3-Year EBIT Growth Rate is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 6.75
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Paragon 28's EBIT for the three months ended in Sep. 2024 was $-9.1 Mil.

Paragon 28 EBIT per Share Historical Data

The historical data trend for Paragon 28's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Paragon 28 EBIT per Share Chart

Paragon 28 Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

0.04

0.08

-0.21

-0.80

-0.64

Paragon 28 Quarterly Data
	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
EBIT per Share	Get a 7-Day Free Trial														-0.12	-0.24	-0.18	-0.13	-0.11

Paragon 28 EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Paragon 28's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-52.156	/	82.087
=	-0.64

Paragon 28's EBIT per Share for the quarter that ended in Sep. 2024 is calculated as

	EBIT per Share		(Q: Sep. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-9.102	/	83.560
=	-0.11

EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.66

Paragon 28 (NYSE:FNA) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Paragon 28 EBIT per Share Related Terms

Thank you for viewing the detailed overview of Paragon 28's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Paragon 28 Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Paragon 28 Inc (NYSE:FNA) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

7GQ:Germany

Address

14445 Grasslands Drive, Englewood, CO, USA, 80112

Website

https://www.paragon28.com

Paragon 28 Inc is a medical devices company that develops, distributes, and sells medical devices in the foot and ankle segment of the orthopedic implant marketplace. Its products include plates and plating systems, screws, staples, and nails aimed to address all major foot and ankle procedures including ankle, Charcot, fracture fixation, hallux valgus, hammertoe, and flat foot. The company's suite of surgical solutions comprises nearly 80 product systems to help fit the specific needs of each patient and procedure. Geographically the company generates the majority of its revenue from the United States.

Executives

Mvm Partners, Llc	10 percent owner	OLD CITY HALL, 45 SCHOOL STREET, BOSTON MA 02108
Kristina Wright	director	C/O PARAGON 28, INC., 14445 GRASSLANDS DRIVE, ENGLEWOOD CO 80112
Albert Dacosta	director, officer: See Remarks	C/O PARAGON 28, INC., 14445 GRASSLANDS DRIVE, ENGLEWOOD CO 80112
Robert S Mccormack	officer: See Remarks	C/O VIEWRAY, INC., 2 THERMO FISHER WAY, OAKWOOD VILLAGE OH 44146
Thomas P Schnettler	director	800 NICOLLET MALL, J1012057, MINNEAPOLIS MN 55402-7020
B. Ag Bird	10 percent owner	BAHNHOFSTRASSE 7, ZUG V8 CH-6300
Matthew Jarboe	officer: Chief Commercial Officer	C/O PARAGON 28, INC., 14445 GRASSLANDS DRIVE, ENGLEWOOD CO 80112
Partners Llp Mvm	10 percent owner	30 ST. GEORGE STREET, LONDON X0 W1S SFH
Jonathan I Friedman	officer: General Counsel	DENTSPLY SIRONA INC., 30-30 47TH AVENUE, SUITE 500, LONG ISLAND CITY NY 11101
Lee Rosenthal	10 percent owner	C/O PARAGON 28, INC., 14445 GRASSLANDS DRIVE, ENGLEWOOD CO 80112
Quentin S. Blackford	director	7475 LUSK BLVD., SAN DIEGO CA 92121
Frank S. Bono	officer: Chief Technology Officer	5677 AIRLINE ROAD, ARLINGTON TN 38002
Jason Allan Edie	officer: Chief Technology Officer	C/O PARAGON 28, INC., 14445 GRASSLANDS DRIVE, ENGLEWOOD CO 80112
Erik E Mickelson	officer: Chief Accounting Officer	C/O PARAGON 28, INC., 14445 GRASSLANDS DRIVE, ENGLEWOOD CO 80112
Meghan Scanlon	director	C/O BOSTON SCIENTIFIC CORPORATION, 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA 01752